Cyprenorphine

From WikiMD's WELLNESSPEDIA

Cyprenorphine is an opioid analgesic that was developed in the 1960s. It is a potent antagonist of the mu-opioid receptor, and has been used in scientific research to help understand the function of this receptor.

History[edit]

Cyprenorphine was first synthesized in the 1960s by the pharmaceutical company Hoffmann-La Roche. It was developed as part of a series of related drugs that also includes buprenorphine and diprenorphine, which are still in use today.

Pharmacology[edit]

Cyprenorphine acts as an antagonist at the mu-opioid receptor, which is the primary target of most opioid analgesics. It has a high affinity for this receptor, and can effectively block the effects of other opioids. This has made it a useful tool in scientific research, as it can be used to study the effects of opioids on the body and to develop new treatments for opioid addiction.

Medical uses[edit]

While cyprenorphine is not commonly used in clinical practice, it has been used in scientific research to study the function of the mu-opioid receptor. It has also been used to develop new treatments for opioid addiction, as it can effectively block the effects of other opioids.

Side effects[edit]

Like all opioids, cyprenorphine can cause a range of side effects. These can include nausea, vomiting, constipation, and respiratory depression. It can also cause physical dependence and withdrawal symptoms if used for a long period of time.

See also[edit]


Cyprenorphine gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.